First AD

Second AD

Prostate Cancer

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Prostate Cancer: Evolving Treatment Approaches 

Peer Exchange

Ep. 6: Identifying Nonmetastatic CRPC

Ep. 1: Initiating Therapy for CSPC

Ep. 2: Identifying and Monitoring Testosterone Levels in CSPC

Ep. 3: Addressing Cardiovascular Risk and Events in CSPC

Ep. 4: Currently Approved Therapies for Metastatic CSPC

Ep. 5: Ongoing CSPC Clinical Trials

Ep. 7: Current Treatment and Imaging Options for nmCRPC

Ep. 8: Selecting Optimal AR-Targeted Therapy for nmCRPC

Ep. 9: Neurological AEs and Quality of Life in Treating nmCRPC

Ep. 10: How Has the mCRPC Treatment Landscape Changed?

Ep. 11: Factors in Selecting Therapy for mCRPC

Ep. 12: What is Radium 223

Ep. 13: Avoiding Repeat Lines of AR-Targeted Therapy in mCRPC

Ep. 14: Emerging Agents in the Management of Prostate Cancer